Tanita Mason-Bright

Tanita Mason-Bright is an experienced professional in clinical operations, currently serving as the Director of Clinical Operations at Taysha Gene Therapies since February 2024. Prior to this role, Tanita held the position of Associate Director of Clinical Operations at Chinook Therapeutics, Inc., from January 2023 to February 2024, and worked as a Senior Clinical Trial Manager for rare diseases at Crinetics Pharmaceuticals. Tanita has extensive experience in managing global clinical studies, having held key positions at Novartis Gene Therapies, Astellas Pharma US, and AbbVie, where responsibilities included oversight of various clinical phases and ensuring compliance with regulatory standards. Early career experience includes a role as Associate Scientist II in pharmacology at Abbott Laboratories. Tanita holds a Bachelor of Science degree from the University of Illinois Urbana-Champaign and a Graduate Certificate in Clinical Research Administration from Walden University.